Skip to main content
. Author manuscript; available in PMC: 2018 Jan 1.
Published in final edited form as: Brain Behav Immun. 2016 Aug 31;59:147–157. doi: 10.1016/j.bbi.2016.08.019

Table 1. Quantification of passive and active coping phenotypes.

K-means cluster designations of defeat latency are reported as average (s) ± SEM. Post-hoc analysis indicated 30 mg/kg treated active coping rats had significantly higher defeat latencies compared to 0 and 10 mg/kg treated active coping rats (* p<0.05).

Dose of RSV Cluster 1 (Passive) Cluster 2 (Active)
0 208.7 ± 47.3 651.3 ± 50.4
10 230.3 ± 21.8 702.1 ± 27.2
30 279.9 ± 8.4 853.9 ± 46.2 *